The α6 Subunit-Containing GABA(A) Receptor: A Novel Drug Target for Inhibition of Trigeminal Activation

Novel treatments against migraine are an urgent medical requirement. α6 subunit-containing GABA(A) receptors (α6GABA(A)Rs) are expressed in trigeminal ganglia (TG), the hub of the trigeminal vascular system (TGVS) that is involved in the pathogenesis of migraine. Here we reveal an unprecedented role...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuropharmacology
Asıl Yazarlar: Fan, Pi-Chuan, Lai, Tzu-Hsuan, Hor, Chia Chun, Lee, Ming Tatt, Huang, Pokai, Sieghart, Werner, Ernst, Margot, Knutson, Daniel E, Cook, James, Chiou, Lih-Chu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6180911/
https://ncbi.nlm.nih.gov/pubmed/30016665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2018.07.017
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller